Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017 ; volume:150 ; number:1 ; day:18 ; month:1 ; year:2024 ; pages:1-9 ; date:1.2024
Journal of cancer research and clinical oncology ; 150, Heft 1 (18.1.2024), 1-9, 1.2024
- Classification
-
Medizin, Gesundheit
- Creator
-
Reitmajer, Markus
Leiter-Stöppke, Ulrike
Nanz, Lena
Amaral, Teresa
Flatz, Lukas
Garbe, Claus
Forschner, Andrea
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-023-05533-0
- URN
-
urn:nbn:de:101:1-2404180713537.377860296875
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Reitmajer, Markus
- Leiter-Stöppke, Ulrike
- Nanz, Lena
- Amaral, Teresa
- Flatz, Lukas
- Garbe, Claus
- Forschner, Andrea
- SpringerLink (Online service)
Other Objects (12)
Decreased Plasma Ascorbate Levels in Stage IV Melanoma Patients
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients
The cost of unresectable stage III or stage IV melanoma in Italy
Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
Approaches to decision-making among late-stage melanoma patients: a multifactorial investigation
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma
Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Decreased Plasma Ascorbate Levels in Stage IV Melanoma Patients
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients
The cost of unresectable stage III or stage IV melanoma in Italy
Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
Approaches to decision-making among late-stage melanoma patients: a multifactorial investigation
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma
Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Decreased Plasma Ascorbate Levels in Stage IV Melanoma Patients
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients
The cost of unresectable stage III or stage IV melanoma in Italy
Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
Approaches to decision-making among late-stage melanoma patients: a multifactorial investigation
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma
Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma